Skip to Content

Abbott Laboratories ABT

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

Capital Allocation

PREMIUM

Abbott Arrives Late to the U.S. Transcatheter Aortic Valve Replacement Party With Portico

Debbie S. Wang Senior Equity Analyst

Analyst Note

| Debbie S. Wang |

While Abbott just received Food and Drug Administration approval on its Portico transcatheter aortic valve replacement device, we continue to hold tempered expectations for the product and are leaving our fair value estimate unchanged. As the fourth entrant to the lucrative U.S. TAVR market, where Edwards Lifesciences and Medtronic dominate the category, narrow-moat Abbott faces a steep uphill battle to carve out a space for itself. Boston Scientific, which was the third entrant more than two years ago, had abruptly exited the U.S. market after it failed to resolve manufacturing issues with the Lotus delivery system. Based on the solid clinical data on Lotus and the device’s distinctive repositioning feature, we thought Boston had a credible chance of penetrating the existing duopoly (though we failed to appreciate the difficulty of scaling up manufacturing). In contrast, Abbott’s Portico offers little over the Edwards Sapien and Medtronic CoreValve franchises. Instead, Portico's record on post-implant paravalvular leakage is significantly worse.

Read Full Analysis

Company Profile

Business Description

Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

Contact
100 Abbott Park Road
Abbott Park, IL, 60064-6400
T +1 224 667-6100
Sector Healthcare
Industry Medical Devices
Most Recent Earnings Jun 30, 2021
Fiscal Year End Dec 31, 2020
Stock Type Aggressive Growth
Employees 109,000

Related